Skip to main content
Log in

Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Objectives

This comparative case-matched analysis investigated feasibility and safety of direct transfemoral (TF) transcatheter aortic valve implantation (TAVI) without pre-dilatation using balloon-expandable devices.

Background

Presently, balloon aortic valvuloplasty (BAV) is considered mandatory preceding transfemoral TAVI with balloon-expandable devices. However, procedural severe adverse events may be associated with BAV.

Methods

26 consecutive patients (study group) received direct TF-TAVI using Edwards Sapien XT (n = 17) or Sapien 3 (n = 9) devices (61.5 % female, 81.3 ± 6.3 years, logEuroSCORE I 15.3 ± 13.2 %). A control group of patients after conventional TF-TAVI was retrieved from our database containing 1153 TAVI patients and matched to the study group regarding baseline and procedural data. Data reporting adheres to VARC-2 definitions.

Results

Device success was 96.2 % (25/26) and 92.3 % (24/26) in study and control groups, respectively (p = 1.00). Procedure time (60.0 ± 54.0 vs. 70.0 ± 29.1 min; p = 0.41), fluoroscopy time (13.3 ± 5.8 vs. 17.8 ± 6.9 min; p = 0.01) and amount of contrast agent (118.7 ± 47.9 vs. 153.0 ± 53.2 ml; p = 0.02) were lower in the study group. All-cause 30-day mortality was 7.7 % (2/26) in both groups, disabling stroke was observed in 3.8 % (1/26) and 7.7 % (2/26) in study and control groups, respectively. Resultant transvalvular mean gradient and effective orifice area (EOA) were 11 ± 5 vs. 11 ± 5 mmHg and 1.6 ± 0.3 vs. 1.5 ± 0.3 cm2. Paravalvular leakage ≥grade II was observed in 0 and 7.7 % (2/26; p = 0.49).

Conclusions

TF-TAVI without pre-dilatation was feasible and safe in this consecutive series of patient regardless of aortic valve morphology, for example. extent of valvular calcification or baseline EOA. This technique resulted in significantly lower fluoroscopy times and amounts of contrast agent while yielding non-inferior hemodynamic and clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

BAV:

Balloon-aortic valvuloplasty

EOA:

Effective orifice area

logEuroSCORE:

Logistic European system for cardiac operative risk evaluation I

MSCT:

Multislice computed tomography

NYHA:

New York Heart Association

PM:

Pacemaker

PVL:

Paravalvular leakage

RVP:

Rapid ventricular pacing

TA:

Transapical

TAVI:

Transcatheter aortic valve implantation

TEE:

Transesophageal echocardiography

TF:

Transfemoral

TTE:

Transthoracic echocardiography

VARC:

Valve Academic Research Consortium

References

  1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 21:1597–1607

    Article  Google Scholar 

  2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  CAS  PubMed  Google Scholar 

  3. Walther T, Thielmann M, Kempfert J, Schroefel H, Wimmer-Greinecker G, Treede H, Wahlers T, Wendler O (2013) One-year multicentre outcomes of transapical aortic valve implantation using the SAPIEN XTTM valve: the PREVAIL transapical study. Eur J Cardiothorac Surg 43:986–992

    Article  PubMed  Google Scholar 

  4. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62–69

    Article  PubMed  Google Scholar 

  5. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Schwedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M, ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS) (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 42:S1–S44

    Article  PubMed  Google Scholar 

  6. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajia P, Sundt TM 3rd, Thomas JD (2014) 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol [Epub ahead of print]

  7. Vahanian A, Himbert D (2011) Transcatheter aortic valve implantation: could it be done without prior balloon valvuloplasty? JACC Cardiovasc Interv 4:758–759

    Article  PubMed  Google Scholar 

  8. Patsalis PC, Al-Rashid F, Neumann T, Plicht B, Hildebrandt HA, Wendt D, Thielmann M, Jakob HG, Heusch G, Erbel R, Kahlert P (2013) Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing. JACC Cardiovasc Interv 6:965–971

    Article  PubMed  Google Scholar 

  9. Cerillo AG, Mariani M, Berti S, Glauber M (2012) Sizing the aortic annulus. Ann Cardiothorac Surg 1:245–256

    PubMed Central  PubMed  Google Scholar 

  10. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA (2012) SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 6:366–380

    Article  PubMed  Google Scholar 

  11. Ben-Dor I, Pichard AD, Satler LF, Goldstein SA, Syed AI, Gaglia MA Jr, Weissman G, Maluenda G, Gonzalez MA, Wakabayashi K, Collins SD, Torguson R, Okubagzi P, Xue Z, Kent M, Lindsay J, Waksman R (2010) Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv 3:1150–1156

    Article  PubMed  Google Scholar 

  12. Tissot CM, Attias D, Himbert D, Ducrocq G, Iung B, Dilly MP, Juliard JM, Lepage L, Détaint D, Messika-Zeitoun D, Nataf P, Vahanian A (2011) Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. EuroIntervention 7:49–56

    Article  PubMed  Google Scholar 

  13. Doguet F, Godin M, Lebreton G, Eltchaninoff H, Cribier A, Bessou JP, Litzler PY (2010) Aortic valve replacement after percutaneous valvuloplasty—an approach in otherwise inoperable patients. Eur J Cardiothorac Surg 38:394–399

    Article  PubMed  Google Scholar 

  14. Kahlert P, Al-Rashid F, Döttger P, Mori K, Plicht B, Wendt D, Bergmann L, Kottenberg E, Schlamann M, Mummel P, Holle D, Thielmann M, Jakob HG, Konorza T, Heusch G, Erbel R, Eggebrecht H (2011) Cerebral embolization during transcatheter aortic valve implantation: a transcranial doppler study. Circulation 126:1245–1255

    Article  Google Scholar 

  15. Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, Kalil Filho R, Mangione J, Buellesfeld L (2011) Feasibility of transcatheter aortic valve implantation without balloon pre-dilation. JACC Cardiovasc Interv 4:751–757

    Article  PubMed  Google Scholar 

  16. Conradi L, Seiffert M, Schirmer J, Koschyk D, Blankenberg S, Reichenspurner H, Diemert P, Treede H (2014) Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe. Eur J Cardiothorac Surg 46:61–66

    Article  PubMed  Google Scholar 

  17. Wendler O, Dworakowski R, Monaghan M, MacCarthy PA (2012) Direct transapical aortic valve implantation: a modified transcatheter approach avoiding balloon predilatation. Eur J Cardiothorac Surg 42:734–736

    Article  PubMed  Google Scholar 

  18. Kempfert J, Meyer A, Kim WK, van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T (2014) First experience without pre-ballooning in transapical aortic valve implantation: a propensity score-matched analysis. Eur J Cardiothorac Surg [Epub ahead of print]

  19. García E, Martin P, Hernandez R, Rodríguez V, Fernández A, Gama V, Almería C, Macaya C (2014) Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve. Catheter Cardiovasc Interv 83:791–795

    Article  PubMed  Google Scholar 

  20. García E, Almeria C, Unzué L, Jiménez P, Cuadrado A, Macaya C (2014) Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography. Catheter Cardiovasc Interv [Epub ahead of print]

  21. Davies WR, Bapat VN, Hancock JE, Young CP, Redwood SR, Thomas MR (2014) Direct TAVI using a balloon-expandable system: a novel technique to eliminate pre-deployment balloon aortic valvuloplasty. EuroIntervention 10:248–252

    Article  PubMed  Google Scholar 

  22. Möllmann H, Kim WK, Kempfer J, Blumenstein J, Liebetrau C, Nef H, van Linden A, Walther T, Hamm C (2014) Transfemoral aortic valve implantation of Edwards SAPIEN XT without predilatation is feasible. Clin Cardiol [Epub ahead of print]

  23. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB, Valve Academic Research Consortium (VARC)-2 (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42:S45–S60

    Article  PubMed  Google Scholar 

  24. R Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/

  25. Ho DE, Imai K, King G, Stuart EA (2011) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:1–28

    Google Scholar 

  26. García E, Almería C, Unzué L, Jiménez-Quevedo P, Cuadrado A, Macaya C (2014) Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography. Catheter Cardiovasc Interv 84(6):868–876

    Article  PubMed  Google Scholar 

  27. Tarantini G, Mojoli M, Purita P, Napodano M, D’Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S (2014) Unravelling the (arte)fact of increased pacemaker. EuroIntervention [Epub ahead of print]

  28. Selle A, Figulla HR, Ferrari M, Rademacher W, Goebel B, Hamadanchi A, Franz M, Schlueter A, Lehmann T, Lauten A (2014) Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion. Clin Res Cardiol [Epub ahead of print]

  29. Isner JM (1991) Acute catastrophic complications of balloon aortic valvuloplasty. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators. J Am Coll Cardiol 17:1436–1444

    Article  CAS  PubMed  Google Scholar 

  30. McKay RG (1991) The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 17:485–491

    Article  CAS  PubMed  Google Scholar 

  31. Serruys PW, Luijten HE, Beatt KJ, DiMario C, deFeyter PJ, Essed CE, Roelandt JR, van den Brand M (1988) Percutaneous balloon valvuloplasty for calcific aortic stenosis. A treatment ‘sine cure’. Eur Heart J 9:782–794

    Article  CAS  PubMed  Google Scholar 

  32. Konigstein M, Ben-Assa E, Abramowitz Y, Steinvil A, Leshem Rubinow E, Havakuk O, Arbel Y, Halkin A, Keren G, Banai S, Finkelstein A (2013) Usefulness of updated valve academic research consortium-2 criteria for acute kidney injury following transcatheter aortic valve implantation. Am J Cardiol 112(11):1807–1811

    Article  PubMed  Google Scholar 

  33. Khawaja MZ, Thomas M, Joshi A, Asrress KN, Wilson K, Bolter K, Young CP, Hancock J, Bapat V, Redwood S (2012) The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention 8(5):563–570

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Lenard Conradi, Hendrik Treede, Ulrich Schäfer and Patrick Diemert are consultants to Edwards Lifesciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Schaefer.

Additional information

L. Conradi and A. Schaefer contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Conradi, L., Schaefer, A., Seiffert, M. et al. Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis. Clin Res Cardiol 104, 735–742 (2015). https://doi.org/10.1007/s00392-015-0836-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-015-0836-1

Keywords

Navigation